United Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. 

CEO
Martine A. Rothblatt
CEOMartine A. Rothblatt
Employees
1,400
Employees1,400
Headquarters
Silver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded
1996
Founded1996
Employees
1,400
Employees1,400

UTHR Key Statistics

Market cap
23.05B
Market cap23.05B
Price-Earnings ratio
20.39
Price-Earnings ratio20.39
Dividend yield
Dividend yield
Average volume
467.84K
Average volume467.84K
High today
$553.86
High today$553.86
Low today
$539.33
Low today$539.33
Open price
$553.86
Open price$553.86
Volume
81.99K
Volume81.99K
52 Week high
$609.35
52 Week high$609.35
52 Week low
$272.12
52 Week low$272.12

Stock Snapshot

As of today, United Therapeutics(UTHR) shares are valued at $542.96. The company's market cap stands at 23.05B, with a P/E ratio of 20.39.

During the trading session on 2026-07-10, United Therapeutics(UTHR) shares reached a daily high of $553.86 and a low of $539.33. At a current price of $542.96, the stock is +0.7% higher than the low and still -2.0% under the high.

Trading volume for United Therapeutics(UTHR) stock has reached 81.99K, versus its average volume of 467.84K.

The stock's 52-week range extends from a low of $272.12 to a high of $609.35.

The stock's 52-week range extends from a low of $272.12 to a high of $609.35.

UTHR News

Simply Wall St 2d
What United Therapeutics's Centralized LungFX EVLP FDA Approval Means For Shareholders - simplywall.st

...

What United Therapeutics's Centralized LungFX EVLP FDA Approval Means For Shareholders - simplywall.st

Analyst ratings

81%

of 16 ratings
Buy
81.3%
Hold
18.8%
Sell
0%

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.